WeVote
Log In

Bill

Bill

SB 1428

RELATING TO MANUFACTURED HEMP PRODUCTS.

2026 Regular Session Introduced by Ron Kouchi

SB 1428 establishes regulatory framework for manufactured hemp products in Hawaii, affecting consumer safety standards and business licensing requirements for producers.

Carried over to 2026 Regular Session.
#departmentofhealth #manufacturedhempproducts #minimumage #prohibition
0
WeVote Research Nonpartisan
Bill Summary · SB 1428

Legislative bill overview

SB 1428 addresses the regulation and oversight of manufactured hemp products in Hawaii. The bill has progressed through initial legislative stages but lacks publicly available detailed provisions at this time due to its early status in the legislative process.

Why is this important

Hemp product regulation affects consumer safety, business operations, and tax revenue in Hawaii. As the hemp market expands nationally, states are establishing frameworks to distinguish hemp-derived products from controlled substances and ensure product quality standards.

Potential points of contention

  • Product definition and scope - Determining which hemp-derived products (CBD, Delta-8, Delta-10, etc.) fall under regulation versus pharmaceutical classification
  • Testing and quality standards - Establishing laboratory testing requirements, potency limits, and contaminant thresholds that could burden small producers
  • Tax implications - Whether manufactured hemp products face excise taxes, sales taxes, or special licensing fees that could affect market competitiveness

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.